JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms.

Am J Hematol 2012 Jul 6;87(7):746-7. Epub 2012 May 6.

Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.

JAK2 (V617F) is associated with a genetic predisposition to its acquisition,as it is preferentially found in subjects with a common constitutional JAK2 haplotype known as 46/1 or GGCC. A recent study suggests that a genetic predisposition to acquisition of MPL mutation may exist in sporadic patients, since an association was found with the JAK2 46/1 haplotype. We genotyped 509 patients with myeloproliferative neoplasms (MPN), 7% of which carrying a somatic mutation of MPL Exon 10. We found that the JAK2 GGCC haplotype was closely associated with JAK2 (V617F) (OR 1.84, P < 0.001) but not with MPL mutations (OR 0.98), suggesting a different genetic background for these molecular lesions.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23229DOI Listing
July 2012
10 Reads

Publication Analysis

Top Keywords

genetic predisposition
8
ggcc haplotype
8
jak2 v617f
8
jak2 ggcc
8
myeloproliferative neoplasms
8
jak2
6
neoplasms mpn
4
mpn carrying
4
haplotype genotyped
4
genotyped 509
4
patients myeloproliferative
4
509 patients
4
46/1 haplotype
4
association jak2
4
mpl mutation
4
acquisition mpl
4
predisposition acquisition
4
exist sporadic
4
sporadic patients
4
carrying somatic
4

Similar Publications